Reported Reactions

Adverse event reports that FDA received

  • Search
  • Watch list

May 2012 adverse event reports that FDA received in the month

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on . The data have the reports that FDA received through .

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on .

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports received

In May 2012, FDA received 53,744 drug adverse event reports. In May 2011, FDA received 46,336.

In May 2012, FDA received 38,916 medical device reports. In May 2011, FDA received 32,197.

By drug reports received, May 2012 was number 9 of the 12 months of 2012. FDA received 51,763 drug reports a month on average in the 12 months before May 2012.

Receive date

A month is the month in which FDA first received the report, not the month of the event. A report about an event of an earlier year is in the month in which it came to FDA.

Data version

FAERS release of 29 Oct 2026. MAUDE release of 23 Oct 2026.

Drug reports, three years

Drug reports that FDA received each month, 36 months to May 2012
050,000100,000201020112012

Drugs in the reports

The table has the 141 drug pages with 100 or more reports in May 2012. The rows are in order of name. A drug page with fewer reports is not in the table.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Drugs that the reports of May 2012 name as a suspect product, in order of name
DrugReports in the month
Accutane173
Acetaminophen136
Actemra141
Albuterol sulfate227
Alendronate sodium165
Aleve180
Androgel223
Apidra148
Aspirin299
Avandia645
Avastin351
Avonex666
Betaseron143
Bevacizumab131
Boniva134
Carboplatin205
Celebrex236
Chantix556
Cimzia118
Cisplatin185
Clozaril203
Copaxone132
Coumadin113
Crestor366
Cyclophosphamide462
Cyclosporine107
Cymbalta227
Cytarabine149
Desvenlafaxine succinate147
Dexamethasone214
Dianeal585
Dianeal Low Calcium W/Dextrose 1 5%249
Dianeal Pd-2 W/Dextrose 1 5%104
Digoxin151
Diovan171
Docetaxel126
Doxorubicin hydrochloride388
Drospirenone and ethinyl estradiol228
Duragesic-100138
Effexor147
Elspar126
Enbrel1,991
Erlotinib hydrochloride164
Etoposide162
Exjade160
Extraneal171
Faslodex137
Fentanyl-100190
Flolan120
Fluorouracil176
Forteo654
Fosamax470
Fosamax Plus D103
Gabapentin136
Gilenya203
Gleevec196
Herceptin121
Humira704
Ibuprofen230
Incivek162
Infliximab214
Januvia111
Lamictal108
Lamotrigine119
Lantus184
Letairis294
Levothyroxine sodium105
Lipitor617
Lisinopril128
Lucentis178
Lyrica781
Mabthera218
Metformin hcl187
Methadone hcl104
Methadose115
Methotrexate294
Mirena1,020
Naproxen sodium788
Neurontin203
Nexavar131
Nexium711
Norvasc113
Nuvigil1,252
Omeprazole200
Paclitaxel179
Paxil153
Pegasys220
Plan B One-Step531
Plavix160
Pletal171
Pradaxa849
Prednisolone157
Prednisone373
Premarin100
Prilosec293
Prilosec OTC462
Prolia100
Propecia110
Ramipril133
Rebif417
Remicade1,229
Revatio108
Revlimid472
Ribavirin224
Risperdal112
Rituximab169
Seroquel368
Sertraline hydrochloride107
Simponi112
Simvastatin127
Soliris998
Solostar107
Stelara113
Sutent243
Symbicort219
Tacrolimus127
Tarceva111
Tasigna115
Tiotropium bromide322
Toprol-Xl104
Tracleer424
Treanda864
Tykerb477
Tysabri2,356
Velcade177
Veramyst103
Viagra204
Victoza115
Vincristine217
Votrient122
Warfarin sodium142
Xalatan117
Xarelto313
Xeloda318
Xolair131
Yasmin647
Yaz786
Zelboraf104
Zoledronoc Acid310
Zoloft181
Zometa201

Reaction terms in the reports

The table has the 145 reaction terms with 250 or more reports in May 2012. The rows are in order of name. One report can record more than one term.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Reaction terms that the drug reports of May 2012 record, in order of name
Reaction term (MedDRA) and plain meaningReports in the month
Abdominal discomfortstomach discomfort468
Abdominal distensiona bloated abdomen282
Abdominal painstomach or belly pain839
Abdominal pain upperupper stomach pain665
Adverse eventan unwanted medical event, type not specified257
Agitationrestlessness260
Alopeciahair loss329
Amnesiamemory loss283
Anaemialow red blood cells806
Anxietyanxiety1,528
Arthralgiajoint pain990
Arthritis291
Astheniaweakness or lack of energy1,166
Asthmaasthma330
Atrial fibrillationan irregular heart rhythm384
Back painback pain813
Balance disorderproblems with balance337
Blood glucose increasedraised blood sugar reading452
Blood pressure increaseda raised blood pressure reading463
Bronchitischest infection323
Cardiac arrestthe heart stopped302
Cardiac disorder400
Cardiac failureheart failure303
Cardiac failure congestivecongestive heart failure574
Cerebrovascular accidentstroke874
Chest discomfortchest discomfort399
Chest painchest pain910
Chillschills or shivering358
Cholelithiasisgallstones275
Chronic obstructive pulmonary diseaseCOPD, a long-term lung disease270
Condition aggravatedthe condition being treated got worse504
Confusional stateconfusion497
Constipationconstipation529
Contusiona bruise338
Convulsion570
Coughcough720
Deaththe patient died; cause not stated by this term2,425
Decreased appetitereduced appetite664
Deep vein thrombosisa blood clot in a deep vein588
Dehydrationdehydration527
Depressionlow mood1,160
Device expulsionthe device came out457
Diabetes mellitusdiabetes324
Diarrhoealoose or frequent stools1,667
Disease progressionthe disease advanced374
Dizzinesslight-headedness or unsteadiness1,489
Drug dose omissiona dose was missed371
Drug effect decreasedthe medicine had less effect254
Drug hypersensitivityan allergic-type reaction (the term names a medicine)479
Drug ineffectivethe medicine did not work as expected2,417
Drug interactionan interaction between medicines473
Dry mouthdry mouth250
Dyspepsiaindigestion443
Dysphagiadifficulty swallowing349
Dyspnoeashortness of breath1,971
Emotional distressemotional distress664
Epistaxisnosebleed261
Erythemaskin redness472
Falla fall1,369
Fatiguetiredness2,086
Feeling abnormalfeeling odd or not right803
Femur fracture487
Foetal exposure during pregnancythe unborn baby was exposed to the medicine402
Gait disturbancedifficulty walking739
Gastrointestinal haemorrhagebleeding in the stomach or bowel341
Gastrooesophageal reflux diseaseacid reflux495
General physical health deteriorationgeneral decline in health568
Haemoglobin decreasedlow haemoglobin523
Haemorrhagebleeding353
Headachehead pain1,962
Heart rate increaseda fast heart rate reading318
Hyperhidrosisexcessive sweating398
Hypersensitivityan allergic-type reaction492
Hypertensionhigh blood pressure803
Hypoaesthesianumbness591
Hypotensionlow blood pressure650
Inappropriate schedule of drug administrationthe medicine was taken at the wrong times288
Infectionan infection, type not specified454
Influenza like illnessflu-like symptoms287
Injection site erythemaredness where the injection was given357
Injection site painpain where the injection was given495
Injurya physical injury870
Insomniadifficulty sleeping962
Intentional drug misuse565
Joint swellinga swollen joint282
Liver disorder286
Loss of consciousnesspassing out488
Malaisegeneral feeling of being unwell1,548
Maternal exposure during pregnancythe mother took the medicine during pregnancy368
Memory impairmentmemory problems423
Menstruation irregularirregular periods363
Migrainemigraine286
Multiple sclerosis relapsea flare of multiple sclerosis357
Muscle spasmsmuscle cramps544
Muscular weaknessmuscle weakness460
Musculoskeletal painpain in muscles or bones280
Myalgiamuscle pain486
Myocardial infarctionheart attack946
Nasopharyngitisa cold418
Nauseafeeling sick2,268
Neoplasm malignanta cancer, type not specified419
Neutropenialow neutrophils, a type of white blood cell334
No adverse eventno adverse event was reported477
Oedema peripheralswelling of the legs, ankles or hands871
Off label useused for a purpose or in a way not on the label703
Oropharyngeal painsore throat298
Osteoarthritis280
Osteoporosisthinning of the bones260
Overdosea dose above the recommended amount379
Painpain, site not specified2,299
Pain in extremitypain in an arm or leg1,061
Palpitationsawareness of the heartbeat451
Paraesthesiatingling or pins and needles454
Platelet count decreasedlow platelet count358
Pleural effusionfluid around the lung251
Pneumonialung infection1,153
Product quality issuea problem with the product itself413
Pruritusitching706
Pulmonary embolisma blood clot in the lung793
Pyrexiafever1,226
Rashskin rash1,059
Renal failurekidney failure476
Renal failure acute459
Respiratory failurethe lungs could not supply enough oxygen311
Rheumatoid arthritisrheumatoid arthritis, an inflammatory joint disease266
Sepsisa severe body-wide response to infection414
Sinusitissinus infection307
Somnolencedrowsiness558
Stressstress274
Suicidal ideationthoughts of suicide332
Syncopefainting385
Tachycardiafast heart rate335
Thrombocytopenialow platelets367
Thrombosis252
Toxicity to various agentspoisoning or toxic effect of one or more substances308
Tremorshaking582
Urinary tract infectionbladder or urinary infection570
Urticariahives402
Vision blurredblurred vision392
Visual impairmentreduced vision351
Vomitingbeing sick1,552
Weight decreasedweight loss750
Weight increasedweight gain532
White blood cell count decreasedlow white cell count334
Wrong technique in drug usage processthe medicine was used in the wrong way346

Devices in the reports

The table has the 44 device pages with 100 or more reports in May 2012. The rows are in order of name. A device page with fewer reports is not in the table.

FDA says:

MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices.

Source: openFDA, Manufacturer and User Facility Device Experience. The site read the page on .

Device brand names that the device reports of May 2012 name, in order of name
Brand nameReports in the month
Access387
Accu-Chek Multiclix105
Activa125
Animas Insulin Infusion Pump302
Cypher Sirolimus-Eluting Coronary Stent228
Durata Sts Optim Active Fixation Df-4 Connector164
Eon Mini IPG, 16-Channel Rechargeable175
Flogard1,365
Homechoice628
HomeChoice Automated PD Set with Cassette206
Homechoice Pro336
Infusor142
LifeVest WCD 4000 System201
M Series137
Nucleus 24 Channel Cochlear Implant System154
Octrode Lead Kit, 60cm Length115
Onetouchping Glucosemgmtsystem729
Ot Ping Meter523
Ot Ultralink Meter536
Ot Verio Iq Meter162
Ot Verio Meter188
Ot Verio Pro Meter248
Paradigm Insulin Infusion Pump132
Paradigm Real-Time Insulin Infusion Pump500
Paradigm Real-Time Revel Insulin Infusion Pump273
Perclose Proglide 6f Suture Mediated Closure Smc System195
Powered Wheelchair140
Precision?173
Promus Element105
Restore Ultra154
Riata Active Fixation507
Riata Passive Fixation104
Riata St Active Fixation168
Sm204 M-Series W/Big Wheel114
Tendril Sdx141
Tendril St101
Tension Free Vaginal Tape222
Terumo Advanced Perfusion System 1115
TotalCare Bed134
Transtar Stretcher134
Trilogy 100223
Unknown Depuy Asr Femoral Head123
Versacare Bed120
Xience V Everolimus Eluting Coronary Stent System101

Cite this page

Reported Reactions. May 2012: adverse event reports received by FDA. https://reportedreactions.com/month/2012-05/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of . Reports received through .

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The device counts come from the openFDA Device Adverse Event (MAUDE) bulk files, release of 23 Oct 2026. The files have the reports that FDA received through 30 Sep 2026. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

Can the count for May 2012 change?

Yes. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases. This page has the count of the openFDA release of 29 Oct 2026: 53,744 drug reports.

Does a month with many reports mean that something occurred in that month?

Not by itself. The date is the date on which FDA received the report, not the date of the event. FDA says:

Many factors can influence whether or not an event will be reported, such as the time a product has been marketed and publicity about an event.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

How does a person report an adverse event?

FDA runs MedWatch, a program that takes voluntary reports from health professionals, patients and consumers. The guide on how to report has the links.